Literature DB >> 12676587

Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene.

David Mu1, Liyun Chen, Xiping Zhang, Lei-Hoon See, Christina M Koch, Clifford Yen, James Jiayuan Tong, Lori Spiegel, Ken C Q Nguyen, Allyson Servoss, Yue Peng, Lin Pei, Jeffrey R Marks, Scott Lowe, Timothy Hoey, Lily Yeh Jan, W Richard McCombie, Michael H Wigler, Scott Powers.   

Abstract

Representational difference analysis (RDA) of human breast cancer was used to discover a novel amplicon located at chromosomal region 8q24.3. We examined a series of breast cancer samples harboring amplification of this region and determined that KCNK9 is the sole overexpressed gene within the amplification epicenter. KCNK9 encodes a potassium channel that is amplified from 3-fold to 10-fold in 10% of breast tumors and overexpressed from 5-fold to over 100-fold in 44% of breast tumors. Overexpression of KCNK9 in cell lines promotes tumor formation and confers resistance to both hypoxia and serum deprivation, suggesting that its amplification and overexpression plays a physiologically important role in human breast cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676587     DOI: 10.1016/s1535-6108(03)00054-0

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  93 in total

Review 1.  The 2P-domain K+ channels: role in apoptosis and tumorigenesis.

Authors:  Amanda J Patel; Michel Lazdunski
Journal:  Pflugers Arch       Date:  2004-05-05       Impact factor: 3.657

2.  Selective block of the human 2-P domain potassium channel, TASK-3, and the native leak potassium current, IKSO, by zinc.

Authors:  Catherine E Clarke; Emma L Veale; Paula J Green; Helen J Meadows; Alistair Mathie
Journal:  J Physiol       Date:  2004-07-29       Impact factor: 5.182

3.  Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.

Authors:  Rikki H Chokshi; Aaron T Larsen; Brijesh Bhayana; Joseph F Cotten
Journal:  Mol Pharmacol       Date:  2015-08-12       Impact factor: 4.436

4.  Mitochondrial expression of the two-pore domain TASK-3 channels in malignantly transformed and non-malignant human cells.

Authors:  Zoltán Rusznák; Gábor Bakondi; Lívia Kosztka; Krisztina Pocsai; Beatrix Dienes; János Fodor; Andrea Telek; Mónika Gönczi; Géza Szucs; László Csernoch
Journal:  Virchows Arch       Date:  2007-12-20       Impact factor: 4.064

5.  TASK3 and its role in neuro and systemic oncogenesis.

Authors:  Shailendra Kapoor
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

Review 6.  Gating the pore of potassium leak channels.

Authors:  Asi Cohen; Yuval Ben-Abu; Noam Zilberberg
Journal:  Eur Biophys J       Date:  2009-04-29       Impact factor: 1.733

7.  Modulation of potassium channel function confers a hyperproliferative invasive phenotype on embryonic stem cells.

Authors:  Junji Morokuma; Douglas Blackiston; Dany S Adams; Guiscard Seebohm; Barry Trimmer; Michael Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-17       Impact factor: 11.205

8.  Discrete change in volatile anesthetic sensitivity in mice with inactivated tandem pore potassium ion channel TRESK.

Authors:  Yun Jeong Chae; Jianan Zhang; Paul Au; Marta Sabbadini; Guo-Xi Xie; C Spencer Yost
Journal:  Anesthesiology       Date:  2010-12       Impact factor: 7.892

9.  Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation.

Authors:  Robert Lucito; John Healy; Joan Alexander; Andrew Reiner; Diane Esposito; Maoyen Chi; Linda Rodgers; Amy Brady; Jonathan Sebat; Jennifer Troge; Joseph A West; Seth Rostan; Ken C Q Nguyen; Scott Powers; Kenneth Q Ye; Adam Olshen; Ennapadam Venkatraman; Larry Norton; Michael Wigler
Journal:  Genome Res       Date:  2003-09-15       Impact factor: 9.043

Review 10.  Imprinting evolution and human health.

Authors:  Radhika Das; Daniel D Hampton; Randy L Jirtle
Journal:  Mamm Genome       Date:  2009-10-15       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.